← back to search

Marco Novelli

Ospedale Civile Di Ivrea · IT
Area of research
Surgery · Oncology
Research interest
Research interests include Esophageal Cancer Research and Treatment, Genetic factors in colorectal cancer, Gastric Cancer Management and Outcomes, and Pancreatic and Hepatic Oncology Research.
h-index
41
citations
8,960
works
187
NIH funding
—
primary concept
Medicine
email
matteo.rottoli@unibo.it

Recent publications

Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer.
2026cited by 3position: contributordoi
Supplementary Figures S1-S17 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 7 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Figure 1 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 6 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 2 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 8 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 4 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 6 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Data from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 7 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 1 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 4 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Figure 2 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 9 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 10 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Note on Modelling 1 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Figures S1-S17 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Note on Modelling 1 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Figure 3 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 2 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 10 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 3 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Figure 4 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 8 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 1 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 5 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 5 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 3 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi
Supplementary Table 9 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Junpei Soeda · Institute for Liver Health3 papers (2013–2015)Jude A. Oben · St Thomas' Hospital3 papers (2013–2015)Angelina Mouralidarane · University College London3 papers (2013–2015)Lucilla Poston · St Thomas' Hospital3 papers (2013–2015)Paul Taylor · King's College London3 papers (2013–2015)Ruma Saraswati · University College London Hospitals NHS Foundation Trust3 papers (2013–2015)— · 2 papers (2013–2015)Manlio Vinciguerra · Institut Pasteur2 papers (2014–2015)Joaquim Pombo · MRC London Institute of Medical Sciences2 papers (2013–2014)Maria O’Donovan · University of Cambridge1 papers (2012–2012)— · 1 papers (2017–2017)— · 1 papers (2025–2025)Kari Juhani Syrjänen · University of Helsinki1 papers (2025–2025)Roger M Feakins · University College Hospital1 papers (2025–2025)Andrew Dawes · Homerton University Hospital1 papers (2025–2025)Cinzia Papadia · Imperial College London1 papers (2025–2025)Laura Marelli · Homerton University Hospital1 papers (2025–2025)Ray Shidrawi · 1 papers (2025–2025)Viktor H. Koelzer · University of Basel1 papers (2017–2017)Sharon M. Hall · University of California, San Francisco1 papers (2022–2022)